Publication date: Available online 27 August 2020Source: Cancer/RadiothérapieAuthor(s): T. Haaser, Y. Constantinidès, C. Dejean, A. Escande, P. Le Tallec, F. Lorchel, S. Marty, S. Thureau, F. Huguet, J.-L. Lagrange, pour la Commission éthique de la SFRO
Thu Aug 27, 2020 21:07
Publication date: Available online 27 August 2020Source: Cancer/RadiothérapieAuthor(s): P. Decazes, S. Hapdey, A. Larnaudie, J. Thariat, S. Thureau
Thu Aug 27, 2020 21:07
Publication date: Available online 26 August 2020Source: Cancer/RadiothérapieAuthor(s): M. Lapeyre, J. Biau, J. Miroir, J. Moreau, B. Gleyzolle, L. Brun, S. Racadot, P. Graff-Cailleaud
Thu Aug 27, 2020 21:07
Publication date: Available online 26 August 2020Source: Cancer/RadiothérapieAuthor(s): C. Beaudelot, E. Bayart, J. Thariat, C. Bourgier, F. Denis, M. Hatt, D. Pasquier, C. Verry, É. Deutsch, A. Levy
Thu Aug 27, 2020 21:07
Publication date: Available online 26 August 2020Source: Cancer/RadiothérapieAuthor(s): M.-C. Biston, S. Chiavassa, V. Grégoire, J. Thariat, T. Lacornerie
Thu Aug 27, 2020 21:07
Publication date: Available online 27 August 2020Source: Critical Reviews in Oncology/HematologyAuthor(s): Edgardo Somigliana, Giorgia Mangili, Fabio Martinelli, Stefania Noli, Francesca Filippi, Alice Bergamini, Luca Bocciolone, Barbara Buonomo, Fedro Peccatori
Thu Aug 27, 2020 16:34
Publication date: October 2020Source: European Journal of Cancer, Volume 138Author(s): Christoffer Gebhardt, Paolo Ascierto, Victoria Atkinson, Pippa Corrie, Reinhard Dummer, Dirk Schadendorf
Thu Aug 27, 2020 20:45
Publication date: Available online 26 August 2020Source: European Journal of Surgical OncologyAuthor(s): Fabio Carboni, Orietta Federici, Settimio Zazza, Isabella Sperduti, Mario Valle
Thu Aug 27, 2020 19:59
Publication date: Available online 26 August 2020Source: European Journal of Surgical OncologyAuthor(s): R. Lo Dico, M. Faron, Y. Yonemura, O. Glehen, M. Pocard, A. Sardi, M. Hübner, D. Baratti, G. Liberale, A. Kartheuser, I. de Hingh, P. Sugarbaker, W. Ceelen, B. Moran, M. Robella, F. Quenet, L. Sideris, D. Goere, M. Limbert, P. Sammartino
Thu Aug 27, 2020 19:59
Publication date: Available online 26 August 2020Source: European Journal of Surgical OncologyAuthor(s): Lei Lou, Fengzhu Lv, Xin Wu, Yuehong Li, Xianghong Zhang
Thu Aug 27, 2020 19:59
Future Oncology, Ahead of Print.
Thu Aug 27, 2020 14:38
Abstract Using document review, we identified 963 publicly accessible NIH RePORT publications across the 16 funded U54 Partnerships to Advance Cancer Health Equity (PACHE) center programs. Using the 868 publications that met criteria, we determined the frequency of publications across the funded PACHE programs by longevity; reported the frequency of studies focused on cancer health disparities; determined the proportion of institutions serving underserved health disparity populations,...
Thu Aug 27, 2020 03:00
Endometrial cancer (EC) is a common gynecologic malignancy worldwide. This study investigated the regulatory effects of circular RNA (circRNA) hsa_circ_0002577 on the tumorigenesis of EC.
Wed Aug 26, 2020 03:00
Enhancer of Zester Homolog 2 (EZH2), a histone lysine methyltransferase and the catalytic component of Polycomb Repressive Complex 2, has been extensively investigated as a chromatin regulator and a transcriptional suppressor by methylating H3 at lysine 27 (H3K27). EZH2 is upregulated or mutated in most cancers, and its expression levels are negatively associated with clinical outcomes. However, the current developed small molecule inhibitors targeting EZH2 enzymatic activities could not inhibit...
Thu Aug 27, 2020 18:05
Abstract Purpose Stereotactic biopsies are routinely used to establish a histological diagnosis of unclear cerebral pathologies. Intraoperatively, frozen-section analysis often confirms diagnostic tissue but also exhibits methodological pitfalls. Intraoperative five-aminolevulinic acid (5-ALA)-fluorescence has been described not only in gliomas but also in other cerebral pathologies. In this study, we assessed the 5-ALA contribution...
Thu Aug 27, 2020 03:00
There was no study investigating real-world utilization and outcome of LCT in Osimertinib-treated NSCLC with oligo-residual disease. This study was to analyze the clinical value of local consolidative therapy ...
Thu Aug 27, 2020 03:00
To perform a clinical audit to assess adherence to standard clinical practice for the diagnosis, treatment, and follow-up of patients undergoing radiotherapy for rectal cancer treatment in four European countr...
Thu Aug 27, 2020 03:00
The majority of mucosal head and neck squamous cell carcinoma (HNSCC) patients are treated with definitive radiation therapy (RT) or concurrent chemoradiation (CRT). However, oral cavity squamous cell carcinoma (OCSCC) represents a unique entity in terms of its management and treatment outcomes. Surgery is the main treatment modality for OSCC while postoperative radiation therapy (PORT) is indicated mainly for patients with advanced disease (e.g. pT3-4, pN2-3) or adverse pathologic/treatment features...
Thu Aug 27, 2020 03:00
Pancreatic RT has been used in the neo-adjuvant and adjuvant setting, and for the management of locally advanced or recurrent pancreatic tumours. The techniques, target volume definitions and fractionation schemes vary considerably in the published literature, even for the same indication. The aim of this technical RT guideline is to provide clinicians with consensus recommendations for target volume delineation (including imaging and patient-set up) for the treatment of pancreatic cancer in different...
Thu Aug 27, 2020 03:00
Prostate cancer (PC) is the most frequently diagnosed cancer and the second most common cause of cancer-related deaths in men worldwide [1]. According to D’Amico criteria, the risk of lymph node (LN) metastasis is minimal for low-risk cancer; however, up to 33% of patients with intermediate- or high-risk cancer present with LN metastases at diagnosis [2]. Thus, the benefits of pelvic nodal irradiation for patients with high-risk features of LN metastasis have been debated. Randomized trials have...
Thu Aug 27, 2020 03:00
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου